Immune checkpoint therapy—current perspectives and future directions
P Sharma, S Goswami, D Raychaudhuri, BA Siddiqui… - Cell, 2023 - cell.com
Immune checkpoint therapy (ICT) has dramatically altered clinical outcomes for cancer
patients and conferred durable clinical benefits, including cure in a subset of patients …
patients and conferred durable clinical benefits, including cure in a subset of patients …
Therapeutic targeting of tumour myeloid cells
ST Barry, DI Gabrilovich, OJ Sansom… - Nature Reviews …, 2023 - nature.com
Myeloid cells are pivotal within the immunosuppressive tumour microenvironment. The
accumulation of tumour-modified myeloid cells derived from monocytes or neutrophils …
accumulation of tumour-modified myeloid cells derived from monocytes or neutrophils …
Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression
Glioblastoma (GBM), a highly lethal brain cancer, is notorious for immunosuppression, but
the mechanisms remain unclear. Here, we documented a temporospatial patterning of tumor …
the mechanisms remain unclear. Here, we documented a temporospatial patterning of tumor …
The local microenvironment drives activation of neutrophils in human brain tumors
Neutrophils are abundant immune cells in the circulation and frequently infiltrate tumors in
substantial numbers. However, their precise functions in different cancer types remain …
substantial numbers. However, their precise functions in different cancer types remain …
Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas
Y Ren, Z Huang, L Zhou, P Xiao, J Song, P He… - Nature …, 2023 - nature.com
Diffuse midline glioma-H3K27M mutant (DMG) and glioblastoma (GBM) are the most lethal
brain tumors that primarily occur in pediatric and adult patients, respectively. Both tumors …
brain tumors that primarily occur in pediatric and adult patients, respectively. Both tumors …
Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma
H Liu, Q Zhao, L Tan, X Wu, R Huang, Y Zuo, L Chen… - Cancer cell, 2023 - cell.com
Malignant gliomas are largely refractory to immune checkpoint blockade (ICB) therapy. To
explore the underlying immune regulators, we examine the microenvironment in glioma and …
explore the underlying immune regulators, we examine the microenvironment in glioma and …
Brain macrophage development, diversity and dysregulation in health and disease
Brain macrophages include microglia in the parenchyma, border-associated macrophages
in the meningeal-choroid plexus-perivascular space, and monocyte-derived macrophages …
in the meningeal-choroid plexus-perivascular space, and monocyte-derived macrophages …
Multispectral fluorine-19 MRI enables longitudinal and noninvasive monitoring of tumor-associated macrophages
D Croci, R Santalla Méndez, S Temme… - Science Translational …, 2022 - science.org
High-grade gliomas, the most common and aggressive primary brain tumors, are
characterized by a complex tumor microenvironment (TME). Among the immune cells …
characterized by a complex tumor microenvironment (TME). Among the immune cells …
CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment
J Wen, S Wang, R Guo, D Liu - European Journal of Medicinal Chemistry, 2023 - Elsevier
Abstract ABSTRACT: Colony-Stimulating Factor-1 Receptor (CSF1R) is a receptor tyrosine
kinase that controls the differentiation and maintenance of most tissue-resident …
kinase that controls the differentiation and maintenance of most tissue-resident …
Tumor-associated macrophages in gliomas—basic insights and treatment opportunities
JK Andersen, H Miletic, JA Hossain - Cancers, 2022 - mdpi.com
Simple Summary Macrophages are a specialized immune cell type found in both
invertebrates and vertebrates. Versatile in functionality, macrophages carry out important …
invertebrates and vertebrates. Versatile in functionality, macrophages carry out important …